You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

Pfizer Inc. is rated a Buy with stable guidance, robust pipeline, strong free cash flows & appealing dividend yield. Learn ...

Pfizer Inc. (NYSE:PFE) is one of the latest stocks on Jim Cramer’s radar. Cramer noted that the company could not perform as ...

Jon Smith explains why investors can look across the pond for stocks with attractive dividend forecasts and shares a specific ...

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Nutrien (NTR) declares $0.545/share quarterly dividend, in line with previous. Forward yield 4.04% Payable Jan. 16; for ...

A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer ...

Pfizer beat earnings expectations decisively this morning, with shares of PFE gapping up more than 12% in pre-market trading.

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

NVIDIA Corporation, S&P 500, Pfizer Inc, Pfizer Incorporated. Read The Tokenist (Timothy Fries)'s latest article on Investing.com India.